发明名称 BENZAZEPINE DERIVATIVE USEFUL FOR TREATMENT OF 5HT2C RECEPTOR-ASSOCIATED DISEASE
摘要 <p><P>PROBLEM TO BE SOLVED: To provide certain 1-substituted-2,3,4,5-tetrahydro-3-benzazepine derivatives of formula (I), that are modulators of the 5HT<SB>2C</SB>receptor. <P>SOLUTION: Compounds of the present invention are useful for the prophylaxis or treatment of 5HT<SB>2C</SB>receptor-associated diseases, conditions, or disorders, such as obesity and related disorders. The 5HT<SB>2C</SB>receptor is a validated and well-accepted receptor target for the prophylaxis and/or treatment of 5HT<SB>2C</SB>mediated receptor diseases and disorders, such as obesity, eating disorders, psychiatric disorders, Alzheimer Disease, sexual dysfunction, and disorders related thereto. The present invention is drawn to compounds which bind to the 5HT<SB>2C</SB>receptor and modulate the activity of the 5HT<SB>2C</SB>receptor, and uses thereof. <P>COPYRIGHT: (C)2011,JPO&INPIT</p>
申请公布号 JP2011162564(A) 申请公布日期 2011.08.25
申请号 JP20110118521 申请日期 2011.05.26
申请人 ARENA PHARMACEUTICALS INC 发明人 SMITH BRIAN;GILSON CHARLES III;SCHULZ JEFFREY;SMITH GEOFFREY
分类号 C07D223/16;A61K31/55;A61P1/04;A61P3/00;A61P3/04;A61P9/00;A61P9/10;A61P11/00;A61P13/02;A61P15/10;A61P25/00;A61P25/04;A61P25/06;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/36;A61P43/00;C07C233/13 主分类号 C07D223/16
代理机构 代理人
主权项
地址